Attributes | Values |
---|
rdf:type
| |
rdfs:seeAlso
| |
Description
| - A study of familial hyperlipoproteinemias, the metabolic syndrome and their phenotypic expressionin correlation with genotype findings. Determination of impact of the metabolic disorder on atherogenesis and the vessel wall function. Evaluation of utility of the genetic approaches and the methods of molecular biology in the clinical practice. Possibilities of influencing hyperlipoproteinemia and other cardiovascular risk factors by treatment of the underlying metabolic defect. (en)
- Studie familiárních hyperlipoproteinémií, metabolického syndromu a jejich fenotypického vyjádření ve vztahu k nálezům v genotypu sledování vlivu metabolické poruchy na rozvoj aterosklerózy a funkci cévní stěny. Posouzení možnosti využití genetických a molekulárně biologických metod v klinické praxi. Možnosti ovlivnění hyperlipoproteinémií a prevence kardiovaskulárních komplikací léčbou základního metabolického defektu.
|
Title
| - Familial hyperlipoproteinemias and the metabolic syndrome - genotype to phenotype correlation. (en)
- Familiární hyperlipoproteinémie a metabolický syndrom - korelace genotypu s fenotypem.
|
skos:notation
| |
http://linked.open...avai/cep/aktivita
| |
http://linked.open...kovaStatniPodpora
| |
http://linked.open...ep/celkoveNaklady
| |
http://linked.open...datumDodatniDoRIV
| |
http://linked.open...i/cep/druhSouteze
| |
http://linked.open...ep/duvernostUdaju
| |
http://linked.open.../cep/fazeProjektu
| |
http://linked.open...ai/cep/hlavniObor
| |
http://linked.open...hodnoceniProjektu
| |
http://linked.open...vai/cep/kategorie
| |
http://linked.open.../cep/klicovaSlova
| - genetics;genetic epidemilogy;familial hyperlipoproteinemia;dyslipidemia;metabolic syndrome;apoE, Lp(a), apoB polymorphism;endothelial dysfunction;vessel wall function (en)
|
http://linked.open...ep/partnetrHlavni
| |
http://linked.open...inujicichPrijemcu
| |
http://linked.open...cep/pocetPrijemcu
| |
http://linked.open...ocetSpoluPrijemcu
| |
http://linked.open.../pocetVysledkuRIV
| |
http://linked.open...enychVysledkuVRIV
| |
http://linked.open...okUkonceniPodpory
| |
http://linked.open...okZahajeniPodpory
| |
http://linked.open...iciPoslednihoRoku
| |
http://linked.open...atUdajeProjZameru
| |
http://linked.open.../vavai/cep/soutez
| |
http://linked.open...usZobrazovaneFaze
| |
http://linked.open...ai/cep/typPojektu
| |
http://linked.open...jektu+dodavatelem
| - Patients with familial hyperlipid.and with metabolic syndrome were examined by the molecular biology methods and clinically.The development of atherosclerosis was studied effect of the influence of the lipid lowering therapy on lipids,endoth.dysfunction. (en)
- Nemocní s familiárními hyperlipoprotein. a metabol.syndromem byli vyšetřováni metodami molekulární genetiky,klin.a byl studován rozvoj aterosklerózy,vliv hypolipidemické léčby na lipidové parametry i na endoteliální dysfunkci. (cs)
|
http://linked.open...tniCyklusProjektu
| |
http://linked.open.../cep/klicoveSlovo
| - metabolic syndrome
- dyslipidemia
- endothelial dysfunction
- genetics
- Lp(a)
- apoB polymorphism
- apoE
- familial hyperlipoproteinemia
- genetic epidemilogy
|
is http://linked.open...vavai/riv/projekt
of | - Hypolipidemic drugs, blood pressure, heart rate, heart rate variability and sympathetic activity
- Horká témata současné lipidologie v každodenní praxi, metabolický syndrom, HDL-C, nová hypolipidemika
- Hot topics of lipidology
- Hyperlipoproteinémie a dyslipoproteinémie
- Approach to dyslipidemia in the elderly
- Dyslipidémie u metabolického syndromu
- Lipoprotein lipase - function, structure, regulation, gene polymorphisms, pathophysiology
- Lipoprotein lipase: Function, structure, regulation, genetic polymorphisms, pathophysiology
- Familial dysbetalipoproteinemia in three patients with apoE2*(Arg136Cys) gene variant
- Actual hypolipidemic therapy
- Fluvastatinum
- New variants in the apolipoprotein AV gene in individuals with extreme triglyceride levels
- News in hypolipidemic therapy
- New strategies in the treatment of dyslipidaemia: do we know how?
- Novinky v léčbě dyslipidémií
- Statiny: farmakologický přehled
- Effect of rosiglitazone on homocysteine and creatinine levels in patients with type 2 diabetes (1)
- Hypertriglyceridemia: Interaction between APOE and APOA5 variants
- Effect of rosiglitazone on homocysteine and creatinine levels in patients with type 2 diabetes (2)
- Atorvastatin
- Decrease in serum dehydroepiandrosterone level after fenofibrate treatment in males with hyperlipidemia
- Effect of rosiglitazone on homocysteine and creatinine levels in patients with type 2 diabetes
- Editorial
- Hyperlipoproteinemias
- Ser19--Trp polymorphism within the apolipoprotein AV gene in hypertriglyceridaemic people
- Treatment of hyperlipidemia - modern trends
- Moderní trendy farmakoterapie hyper-dyslipoproteinémií (2)
- Statin-based lipid-lowering therapy in patients with acute coronary syndrome
- Increased levels of pregnancy-associated plasma protein-A in patients with hypercholesterolemia and diabetes: the effect of atorvastatin treatment
- Atorvastatinum
- Atorvastatin
- Co víme o sekundárních dyslipidémiích?
|
is http://linked.open...vavai/cep/projekt
of | |